Medical News

RSS

Experts discuss benefits of combining deworming, school feeding programs at meeting with U.K. Parliament

This post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog reports on an event held on Wednesday in London during which John Kufuor, former president of Ghana and winner of the 2011 World Food Prize, addressed the U.K. Parliament "about how school feeding programs can help millions of people currently living in poverty."

10 Feb 2012

Optimal timing of elective delivery is 39 weeks for women with prior cesarean

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report findings that indicate that for women with prior delivery via cesarean section the optimal timing of elective delivery for mother and baby is 39 weeks even after consideration of the risk with continuing pregnancy.

10 Feb 2012

SomaLogic to receive TB biomarkers grant from Gates Foundation

SomaLogic, Inc., announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative that seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.

10 Feb 2012

New cERD method can detect RNAi activity in biological fluids

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its scientists have discovered a novel method for monitoring RNAi activity in blood samples, representing a potential major advance for future development of RNAi therapeutics, other therapeutic modalities, and diagnostics.

10 Feb 2012

LFA seeks grant applications to address important areas of lupus research

The Lupus Foundation of America (LFA) seeks grant applications to advance the science and medicine of lupus and to help improve the quality of lives of all people affected by this disease. The LFA is seeking grant applications to address the following areas of lupus research: cutaneous (skin) lupus, pediatric lupus, adult stem cell transplantation, and neuropsychiatric lupus, which affects the brain and nervous system.

10 Feb 2012

State roundup: Iowa ponders HPV awareness program; Md. workers will see pharmacy plan change; Mass. changes saving money for cities

Iowa's health department would launch a $250,000 public awareness program about the human papillomavirus vaccine under a bill approved today by a Senate subcommittee. ... Senate Study Bill 3097 would allocate $250,000 for the program, which includes vaccinations for low-income women between the ages 19 and 26 who have no other health coverage. The bill was approved today by a Senate Human Resources subcommittee and now heads to the full committee for further consideration.

10 Feb 2012

New link between beta-arrestin and short-term memory

Biomedical scientists at the University of California, Riverside have identified a new link between a protein called beta-arrestin and short-term memory that could open new doors for the therapeutic treatment of neurological disorders, particularly Alzheimer's disease.

10 Feb 2012

Chromosomal microarray provides more information about fetal abnormalities

A nationwide, federally funded study has found that testing a developing fetus' DNA through chromosomal microarray (CMA) provides more information about potential disorders than does the standard method of prenatal testing, which is to visually examine the chromosomes.

10 Feb 2012

New approach for production of tissue culture scaffolds in 3-D arrangements

Scientists at the University of California, San Diego have developed a new method for making scaffolds for culturing tissue in three-dimensional arrangements that mimic those in the body. This advance, published online in the journal Advanced Materials, allows the production of tissue culture scaffolds containing multiple structurally and chemically distinct layers using common laboratory reagents and materials.

10 Feb 2012

UC Riverside uncovers new insight into colon cancer

An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United States. The research provides potential new avenues for diagnosing and treating the disease.

10 Feb 2012

Farmers markets at medical centers may improve public health

Farmers markets at medical centers may contribute to greater wellness in surrounding communities while adding public health value to a market's mission, say Penn State College of Medicine researchers who have developed and evaluated a market created at Penn State Milton S. Hershey Medical Center.

10 Feb 2012

Study shows high cost of defensive orthopaedic care

In a first-ever national survey of orthopaedic surgeons, 96 percent said they have practiced defensive medicine - the ordering of tests, referrals to specialists and hospital admissions primarily to avoid liability and without significant benefit to patients - according to a new study presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons.

10 Feb 2012

New device offers fresh hope for patients with Motor Neurone Disease

Patients suffering from a devastating disease are being given fresh hope through an innovative trial being led by the Sheffield Institute for Translational Neuroscience (SITraN) and Sheffield Teaching Hospitals.

10 Feb 2012

Adaptive radiotherapy may benefit patients with head and neck cancer

Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy (ART) for head and neck cancer.

10 Feb 2012

Smith & Nephew introduces POLARCUP Dual Mobility Hip System

Smith & Nephew, the global medical technology business, is introducing the clinically proven POLARCUP Dual Mobility Hip System to orthopaedic surgeons in the US at this year's American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Francisco.

10 Feb 2012

Longer looks: Former Komen VP's new 'bona fides'; Alzheimer's definition changing?; Palin on her special needs child

Even if you put politics and ideology completely aside, Karen Handel had to resign from Susan G. Komen for the Cure. It's hard to think of the last time an employee did so much damage to such a respected brand in so little time. ... But while Komen will sustain long-term damage, Handel probably will be just fine. Yes, she's lost her position as Komen's vice president for public policy. But Handel has long had political aspirations, and she's now a right-wing cause célèbre.

10 Feb 2012

Ultrasound reliable alternative to X-rays for DDH screening in children

Developmental dislocation (dysplasia) of the hip (DDH) is a common congenital condition in which a child's upper thighbone is dislocated from the hip socket. The condition can be present at birth or develop during a child's first year of life. Plain radiography (X-rays) has long been the gold standard screening modality for this condition in 6-month-old children, despite concerns over exposing very young children to ionizing radiation.

10 Feb 2012

RI Hospital to study treatment that may prevent post-traumatic OA

Rhode Island Hospital has received a grant of $2.2 million from the United States Department of Defense to support a research study on a treatment that may prevent post-traumatic osteoarthritis, a common condition in men and women who suffer joint injuries to the knee and hip.

10 Feb 2012

Cancer-related fatigue linked to muscle mass and strength

Many patients with advanced cancer suffer from cachexia, a condition also called body-wasting or wasting syndrome, which causes significant weight loss, extreme fatigue and reduces quality of life.

10 Feb 2012

Single fibronectin injection can prevent chronic pain development after SCI

Chronic neuropathic pain following a spinal cord injury is common and very difficult to treat, but a new therapeutic strategy requiring a one-time injection into the spinal column has potential to improve patient outcomes.

9 Feb 2012